USP "introductory" patient leaflets
Executive Summary
U.S. Pharmacopeia says it will issue patients' pharmaceutical information leaflets for new drugs within one month after they are approved. Based on FDA-approved physician labeling, the leaflets "are intended to fill an immediate need for information on a temporary basis until a full monograph is developed through USP's consensus process'and added to USP-Dispensing Information, the organization said. The program was approved by USP's Drug Information Division Executive Committee.